HFA Icon

Paulson Builds Stake in Allergan; Supports Valeant

HFA Padded
Mark Melin
Published on
Updated on
Sign up for our E-mail List and Get FREE Access to Exclusive Investment E-books and More!

The heat is being applied to Allergan, Inc. (NYSE:AGN) by a hedge fund executive other than Pershing Square’s William Ackman. Reuters is reporting that John Paulson is among the top 15 holders of Allergan stock.

Allergan

Paulson has built an exposure to Allergan

Paulson’s hedge fund, Paulson & Company, has build an exposure to Allergan, Inc. (NYSE:AGN) of more than six million shares – shares it plans to vote in favor of an unsolicited buyout offer from Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX), Reuters is reporting, citing “people familiar with the matter.”

At issue is a vote to replace the existing Allergan, Inc. (NYSE:AGN) board with board members favoring a deal with Allergan....

Login required to continue reading.

Setup a free account to get access to this article (no credit card required).

View Full Article
Already a member? Log in here
HFA Padded

Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.